Integrated neuromodulation system for mood enhancement of a living human subject

A fluid, non-prescription, blended formulation suitable for oral ingestion by a living human subject, comprising:

• (i) at least two and not more than six different naturally existing nootropic dopamine neurotransmitter agonists, (ii) at least one and not more than four different naturally existing nootropic acetylcholine neurotransmitter agonists, (iii) at least one and not more than three different naturally existing nootropic serotonin neurotransmitter agonists, (iv) at least one and not more than three different naturally existing nootropic GABA neurotransmitter agonists, (v) at least one and not more than three different naturally existing nootropic adenosine antagonists, and a biocompatible and non-toxic liquid carrier medium, wherein the ratio of all individual nootropic neurotransmitter agonists to all individual nootropic adenosine antagonists is proportionally not less than 5:1 and not more than 16:3, wherein the neurotransmitter replenishment balance for the admixture of essential active agents mathematically is zero (“0”) in value, and wherein there is a complete absence of any other kind of nootropic agonist or antagonist.